NASDAQ: PMD - Psychemedics Corporation

Rentabilität für sechs Monate: +15.09%
Dividendenrendite: 0.00%
Sektor: Healthcare

Aktionsplan Psychemedics Corporation

Erweiterter Zeitplan Einfaches Diagramm
Financial Markets by TradingView

Über das Unternehmen Psychemedics Corporation

Psychemedics Corporation provides testing services for the detection of drugs of abuse through the analysis of hair samples in the United States and internationally. The company offers screening and confirmation by mass spectrometry using industry-accepted practices for cocaine, marijuana, and PCP; amphetamines, including ecstasy, eve, and Adderall; opiates, such as heroin, hydrocodone, hydromorphone, oxycodone, oxymorphone, and codeine; synthetic cannabinoids comprising K2, Spice, and Blaze; benzodiazepines consisting of Xanax, Valium, and Ativan; and nicotine, Fentanyl, and alcohol.

weitere details
Its testing results provide quantitative information that could indicate the approximate amount of drug ingested, as well as historical data that could show a pattern of individual drug use over a longer period-of-time. The company offers its services to employers for applicant and employee testing; and treatment professionals, law enforcement agencies, school administrators, and parents concerned about their children's drug use. Psychemedics Corporation was incorporated in 1986 and is headquartered in Acton, Massachusetts.
Zur Vergleichsliste hinzufügen
Auf die Beobachtungsliste
Zum Portfolio hinzufügen
Preishinweis hinzufügen

IPO date 1994-02-17
ISIN US7443752057
Industry Health Care Providers & Services
Sector Health Care
Валюта usd
Валюта отчета usd
Див.доход ао 5.83
Дивиденд ао 0.14
Сайт https://www.psychemedics.com
Цена ао 2.67
Preisänderung pro Tag: 0% (2.67)
Preisänderung pro Woche: 0% (2.67)
Preisänderung pro Monat: 0% (2.67)
Preisänderung über 3 Monate: 0% (2.67)
Preisänderung über sechs Monate: +15.09% (2.32)
Preisänderung pro Jahr: -10.1% (2.97)
Preisänderung über 3 Jahre: -62.55% (7.13)
Preisänderung über 5 Jahre: -70.88% (9.17)
Preisänderung seit Jahresbeginn: 0% (2.67)
Alle Parameter

Unterschätzung

Name Bedeutung Grad
P/S 0.7351 10
P/BV 2.43 6
P/E 0 0
EV/EBITDA -66.05 0
Gesamt: 5.25

Effizienz

Name Bedeutung Grad
ROA, % -31.3 0
ROE, % -62.26 0
Gesamt: 0

Dividenden

Name Bedeutung Grad
Div yield, % 0 0
DSI 0.5714 5.71
Gesamt: 3.2

Pflicht

Name Bedeutung Grad
Debt/EBITDA -9.16 10
Gesamt: 10

Wachstumsimpuls

Name Bedeutung Grad
Rentabilität Revenue, % -41.38 0
Rentabilität Ebitda, % -108.37 0
Rentabilität EPS, % -358.92 0
Gesamt: 0
Weitere Details

Institutionen Volumen Aktie, %
22NW, LP 274418 4.73
Renaissance Technologies, LLC 265563 4.57
Vanguard Group Inc 251283 4.33
RBF Capital, LLC 142142 2.45
Ancora Advisors, Llc 78173 1.35
Blackrock Inc. 77267 1.33
Wedbush Securities Inc 48664 0.84
Geode Capital Management, LLC 36596 0.63
Dimensional Fund Advisors LP 36117 0.62
Crawford Investment Counsel, Inc. 20098 0.35



Aufsicht Berufsbezeichnung Zahlung Geburtsjahr
Mr. Brian Hullinger President, CEO & Director 361.37k 1968 (57 Jahre)
Dr. Werner A. Baumgartner Ph.D. Founder N/A
Ms. Annette Baumgartner Founder N/A
Mr. Michael Weisenhoff Principal Financial & Accounting Manager N/A 1990 (35 Jahre)
Ms. Shannon Shoemaker Chief Revenue Officer 187.82k
Mr. Patrick J. Kinney Jr. Secretary N/A
Ms. Daniella Mehalik Vice President of Finance 126.41k 1990 (35 Jahre)

Adresse: United States, Acton. MA, 289 Great Road - in Google Maps öffnen, Öffnen Sie Yandex-Karten
Webseite: https://www.psychemedics.com